Abstract Submission
Use the form below to submit a single abstract. Although abstract submission is not required to attend the meeting, in-person meeting attendance and an abstract submission is required for all the speakers. The abstracts must describe the purpose, experimental procedures, results, and conclusions of the research in a succinct manner. The accuracy of the submitted abstract is the sole responsibility of the authors. Abstract submitters will choose a session topic below.
The session topics are:
Session 1: Overview of SPOREs
Session 2: Understandings of tumor microenvironment and immunotherapies
Session 3: DNA repair and therapeutic opportunities
Session 4: Biological and socioeconomic influences on survival
Session 5: Early-stage investigators
Session 6: Artificial intelligence and new technologies
Session 7: Novel therapeutic targets
Formatting Requirements
Please follow the instructions below to format an abstract. If your abstract does not follow all formatting requests, it will not be accepted and will have to be redone.
Note: Submissions will not be edited for spelling or grammar and will be accepted “as is.”
- The abstract should be typed single-spaced, using Times New Roman font. Everything but the title should be in normal, 12-point font.
- The abstract’s title should be Bold, 16-Point, Title Case font and should clearly represent the nature of the investigation.
- Skip one line after the title, and list the author’s first and last names, affiliation, city, state, and country.
- Separate multiple authors with a semicolon; and underline the primary author’s name (one primary author per abstract).
- Use one blank line between the title and the authors, the authors, and the body of the abstract, and between paragraphs.
- Use of standard abbreviations is desirable (e.g., BMI), as well as standard symbols for units of measure (e.g., kg, g, mg, mL, L, and %). Place any special or unusual abbreviations in parentheses after the full word the first time that it appears. Use numerals to indicate numbers except to begin sentences. Do not use subheadings (e.g., Methods, Results).
- Simple tables or graphs may be included; however, they must fit within the designated abstract space of one page.
Abstract Submission Deadline: June 6th, 2025, by 4pm EST.
We encourage participants to submit virtual posters that align with the session topics listed. Please use the Poster Submission tab to submit your related poster no later than June 6th, 2025.
Confirmation emails will be sent upon submission.
Abstract submission questions can be addressed to Naveena Basa Janakiram at naveena.basajanakiram@nih.gov.
Please register before submitting an abstract.
OMB No.: 0925-0740
Expiration Date: 9/30/2025
Public reporting burden for this collection of information is estimated to average 20 minutes per response, including the time for reviewing instructions, searching existing data sources, gathering and maintaining the data needed, and completing and reviewing the collection of information. An agency may not conduct or sponsor, and a person is not required to respond to, a collection of information unless it displays a currently valid OMB control number. Send comments regarding this burden estimate or any other aspect of this collection of information, including suggestions for reducing this burden to: NIH, Project Clearance Branch, 6705 Rockledge Drive, MSC 7974, Bethesda, MD 20892-7974, ATTN: PRA (0925-0740). Do not return the completed form to this address.